Karthik V. Natarajan

机构：NewYork–Presbyterian Hospital, Singapore University of Technology and Design, Henry Ford Health, Washington University in St. Louis, University of Michigan, University Hospitals of Cleveland, Columbia University Irving Medical Center, Phoenix Children's Hospital, Valleywise Health, Arizona State University, Columbia University · ORCID：0000-0002-9066-9431

发表论文 209 篇 · 总被引 8718 次 · h-index 44

代表论文

• Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis (2024 · The Lancet · 被引 132)
• Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 90)
• Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults (2025 · JAMA Network Open · 被引 26)
• Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United States, September 2025–February 2026 (2026 · MMWR Morbidity and Mortality Weekly Report · 被引 18)
• Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (2025 · MMWR Morbidity and Mortality Weekly Report · 被引 12)
• Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis (2025 · The Lancet Regional Health - Americas · 被引 10)